ANNX

Annexon Inc.

Price

$5.50

return (12m)

151.14%

p/e

-5.21

p/bv

5.68

DIVIDEND YIELD

0.00%

ANNX price

Annexon

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment ANNX

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

1.11%

3 months

1.10%

1 year

151.14%

2 years

-8.03%

5 years

-67.16%

10 years

0.00%

Asset Comparator

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Fundamentals ANNX

Valuation

P/E

-5.21

Sector -4.38

Industry -4.38

P/BV

5.68

Sector 2.02

Industry 2.02

P/Revenue (PSR)

Sector -4.40

Industry -4.40

EV/EBITDA

-14.95

Sector -263.09

Industry -263.09

EV/EBIT

-14.80

Sector -702.90

Industry -702.90

P/EBITDA

-5.07

Sector -4.39

Industry -4.39

P/EBIT

-5.02

Sector -4.73

Industry -4.73

P/Total Assets

4.29

Sector 1.49

Industry 1.49

P/Net Current Assets

6.91

Sector -11.70

Industry -11.70

P/Working Capital

6.06

Sector -3.19

Industry -3.19

EPS

-1.01

Sector -2.14

Industry -2.14

BVPS

0.93

Sector 1.85

Industry 1.85

Efficiency

Gross Margin

0.00%

Sector 36.74%

Industry 36.74%

EBITDA Margin

Sector -16,244.81%

Industry -16,244.81%

EBIT Margin

Sector -4,202,541.34%

Industry -4,202,541.34%

Operating Margin

0.00%

Sector -38.22%

Industry -38.22%

Net Profit Margins

0.00%

Sector -39.69%

Industry -39.69%

Asset Turnover

0.00

Sector 0.03

Industry 0.03

Profitability

ROE

-108.93%

Sector -65.14%

Industry -65.14%

ROA

-82.36%

Sector -65.53%

Industry -65.53%

ROIC

-567.31%

Sector -2,103.35%

Industry -2,103.35%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

5.53

Sector 2.90

Industry 2.90

Net Debt / EBITDA

3.69

Sector -6.07

Industry -6.07

Net Debt / EBIT

3.66

Sector -8.26

Industry -8.26

Net Debt / Equity

-1.12

Sector -1.07

Industry -1.07

Gross Debt / Equity

0.00

Sector -0.05

Industry -0.05

Equity/Assets

0.76

Sector 0.41

Industry 0.41

Liabilities/Assets

0.24

Sector 0.39

Industry 0.39

Growth

5Y Revenue CAGR

0.00%

Sector -

Industry -

5Y Earnings CAGR

9.23%

Sector -

Industry -

Fundamentals ANNX

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
ANNX Annexon Inc.	$5.50	151.14%	0.00%	-5.21	5.68	-108.93%	0.00%
JNJ Johnson & Johnson	$273.41	58.46%	2.02%	29.66	7.34	24.76%	21.48%
PFE Pfizer Inc.	$28.24	21.45%	6.54%	34.62	1.75	5.07%	6.80%
ABBV AbbVie Inc.	$265.97	33.11%	2.73%	70.02	-74.53	-106.44%	9.81%
NVO Novo Nordisk A/S	$46.48	-9.14%	4.09%	11.13	5.91	53.11%	35.32%
MRK Merck & Co. Inc.	$152.20	87.95%	2.45%	106.68	8.06	7.56%	4.77%
AZN AstraZeneca PLC	$164.95	4.92%	2.07%	22.98	4.77	20.74%	17.02%
BMY Bristol-Myers Squibb Company	$67.61	46.95%	3.93%	14.06	5.85	41.59%	18.87%
ZTS Zoetis Inc.	$76.68	-48.52%	2.77%	11.89	9.88	83.10%	27.49%
REGN Regeneron Pharmaceuticals Inc.	$840.84	43.05%	0.45%	19.09	2.61	13.65%	27.86%
AMGN Amgen Inc.	$442.36	55.11%	2.39%	25.30	18.93	74.80%	22.95%
HALO Halozyme Therapeutics Inc.	$107.62	56.06%	0.00%	27.82	80.17	288.14%	24.86%
MCK McKesson Corporation	$853.71	27.85%	0.38%	22.42	-79.15	-352.96%	1.12%
VRTX Vertex Pharmaceuticals Incorporated	$552.06	41.60%	0.00%	29.26	6.36	21.76%	35.00%
CAH Cardinal Health Inc.	$234.85	58.85%	0.88%	31.61	-19.89	-62.92%	0.67%
HRMY Harmony Biosciences Holdings Inc.	$39.93	9.67%	0.00%	12.18	2.21	18.14%	18.89%
BIIB Biogen Inc.	$221.56	63.02%	0.00%	37.04	1.64	4.43%	8.32%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

ANNX Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Annexon

Annexon Inc.

Average Investor10 user rating

4.0 (2 people)

United States

15 years

Founded: 2011

2020

Time since IPO - 6 years

48

Employees

Annexon Inc. (United States) is listed on the Nasdaq and has a market capitalization of $1.06 billion, with shareholders equity totaling $186.06 million.

The company employs approximately 48 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, Annexon Inc. reported $- in revenue, generating net income of $-202.67 million.

Key financial metrics include a P/E ratio of -5.21, a price-to-book (P/B) ratio of 5.68, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker ANNX.

Market cap

$1.06 billion

Net worth

$186.06 million

$186,060,000.00

Assets

$246.07 million

$246,070,000.00

Total Shares Outstanding

201.00 million

201,000,000

Average Daily Trading Volume

$3.81 million

$3,809,840.00

Sector

Health Care

Industry

Biotechnology

ANNX

ANNX revenue and profits

Financial Results ANNX

DRAG THE FRAME TO SEE MORE DATA

ANNX cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$853.71 22,07% (12M)

P/E

22.42

0.38%

ROE

-352.96%

P/BV

-79.15

CAH - Cardinal Health

$234.85 55,51% (12M)

P/E

31.61

0.88%

ROE

-62.92%

P/BV

-19.89

JNJ - Johnson & Johnson

$273.41 57,54% (12M)

P/E

29.66

2.02%

ROE

24.76%

P/BV

7.34

ABBV - AbbVie

$265.97 31,23% (12M)

P/E

70.02

2.73%

ROE

-106.44%

P/BV

-74.53

MRK - Merck & Co.

$152.20 86,97% (12M)

P/E

106.68

2.45%

ROE

7.56%

P/BV

8.06

AZN - AstraZeneca

$164.95 5,00% (12M)

P/E

22.98

2.07%

ROE

20.74%

P/BV

4.77

PFE - Pfizer

$28.24 21,16% (12M)

P/E

34.62

6.54%

ROE

5.07%

P/BV

1.75

BFRA - Biofrontera

$- -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$853.71 22,07% (12 M)

P/L

22.42

0.38%

ROE

-352.96%

P/VP

-79.15

CAH - Cardinal Health

$234.85 55,51% (12 M)

P/L

31.61

0.88%

ROE

-62.92%

P/VP

-19.89

JNJ - Johnson & Johnson

$273.41 57,54% (12 M)

P/L

29.66

2.02%

ROE

24.76%

P/VP

7.34

ABBV - AbbVie

$265.97 31,23% (12 M)

P/L

70.02

2.73%

ROE

-106.44%

P/VP

-74.53

MRK - Merck & Co.

$152.20 86,97% (12 M)

P/L

106.68

2.45%

ROE

7.56%

P/VP

8.06

AZN - AstraZeneca

$164.95 5,00% (12 M)

P/L

22.98

2.07%

ROE

20.74%

P/VP

4.77

PFE - Pfizer

$28.24 21,16% (12 M)

P/L

34.62

6.54%

ROE

5.07%

P/VP

1.75

Frequently Asked Questions

What is the price of Annexon (ANNX) today?

A cotação de Annexon (ANNX) hoje está em US$ 5.50, com uma variação de 151.14% em relação ao último ano. A cotação de Annexon (ANNX) iniciou o ano negociando na casa dos US$ 5.02 e hoje está em US$ 5.50. Acompanhe o gráfico de cotação em tempo real, a cotação histórica de Annexon (ANNX) e dados de ações do Ibovespa e mercados internacionais.

Quando Annexon (ANNX) paga dividendos?

Annexon (ANNX) não distribuiu dividendos no último ano.

Is Annexon (ANNX) a good investment?

Atualmente, Annexon (ANNX) está cotada a US$ 5.50, com um P/L de -5.21, representando um desvio de -412% em relação ao seu P/L médio histórico. No último ano, a ação apresentou uma variação de 151.14 em sua cotação e distribuiu US$ 0.00 em dividendos, resultando em um Dividend Yield de 0.00%. O retorno total do acionista foi de 151.14%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy Annexon (ANNX) stock?

Investir em ações de Annexon (ANNX) pode ser feito de duas formas: comprando a stock uma empresa estrangeira e é atrelado ao dólar.

How much would 100 shares of Annexon (ANNX) yield today?

A rentabilidade de Annexon (ANNX) foi de 1.11% no último mês, 151.14% no último ano e -67.16% nos últimos 5 anos (já considerando valorização e dividendos).

Nos últimos 12 meses, a empresa pagou um total de US$ 0.00 em dividendos, um Dividend Yield de 0.00%.

Se você quisesse comprar 100 ações de Annexon (ANNX) hoje, o investimento total seria de US$ 550.00, com base na cotação atual de US$ 5.50.

Based on historical performance, the investment would have grown to approximately:

Em 1 ano: US$ 1,381.27
Em 5 anos: US$ 180.62
Em 10 anos: US$ 550.00

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

ANNX

Annexon Inc.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment ANNX

Valuation

Efficiency

Profitability

Dividends

Debt

Growth

COMPARING ANNX WITH OTHER STOCK

current DY: 0.00%

5-year average DY: 0.00%

ABOUT Annexon

Annexon Inc.

United States

15 years

2020

48

PROFIT X PRICE ANNX

Financial Results ANNX

ANNX cash flow

Asset, Revenue and Profit Growth - ANNX

ANNX balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

Frequently Asked Questions